ABSTRACT
Background and aims Previous studies suggest an association between maternal tobacco and caffeine consumption during and outside of pregnancy and offspring mental health. We used an intergenerational polygenic risk scores (PRS) approach to disentangle effects of the maternal environment (intrauterine or postnatal) and pleiotropic genetic effects. Specifically, we 1) validated smoking and caffeine PRS derived from published GWAS for use during pregnancy, 2) compared estimated effects of maternal and offspring PRS on childhood mental health outcomes, and 3) tested associations between maternal and offspring PRS on their own outcomes.
Design PRS were created for smoking and caffeine consumption for 8,196 mothers and 8,237 offspring from the Avon Longitudinal Study of Parents and Children (ALSPAC). Outcomes included mostly mental health and some non-mental health phenotypes (I.e. substance use, personality, BMI and sociodemographic variables). For mothers, 79 phenotypes assessed during and outside of pregnancy, and for offspring, 71 phenotypes assessed in childhood (< 10 years) and adolescence (11-18 years) were included. Linear and logistic regressions were run to assess PRS in relation to maternal and offspring phenotypes.
Findings First, the maternal smoking and caffeine PRS were associated with these behaviours during pregnancy. Second, the maternal and offspring smoking PRS both showed evidence (permutation corrected P < 0.05) of association with reduced anxiety symptoms in childhood (βmaternal = −0.033; βoffspring = −0.031) and increased conduct disorder symptoms (βmaternal = 0.024; βoffspring = 0.030). Finally, the maternal and offspring smoking PRS were associated with own sensation seeking phenotypes in mothers and adolescence (e.g. increased symptoms of externalising disorders, extraversion, and monotony avoidance), but the caffeine PRS showed weaker evidence for associations with mental health outcomes. Our results indicate that the smoking PRS is most likely pleiotropic with sensation seeking personality traits. However, these results need replication in independent samples, using techniques more robust to pleiotropy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was performed in the UK Medical Research Council Integrative Epidemiology Unit (grant number: MC_UU_00011/7) and also supported by the National Institute for Health Research (NIHR) Bristol Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The MRC also funded KEEs PhD studentship. LZ was supported by a UK Medical Research Council fellowship (grant number G0902144). GCS was supported by the Medical Research Council [New Investigator Research Grant, MR/S009310/1] and the European Joint Programming Initiative A Healthy Diet for a Healthy Life (JPI HDHL, NutriPROGRAM project, UK MRC MR/S036520/1]. This research was also conducted as part of the CAPICE (Childhood and Adolescence Psychopathology: unravelling the complex etiology by a large Interdisciplinary Collaboration in Europe) project, funded by the European Unions Horizon 2020 research and innovation programme, Marie Sklodowska Curie Actions MSCA-ITN-2016 Innovative Training Networks under grant agreement number 721567. This study was supported by the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health. A comprehensive list of grant funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available through application to the research executive of ALPSAC. Please note that the study website contains details of all the data that is available through a fully searchable data dictionary and variable search tool: http://www.bristol.ac.uk/alspac/researchers/our-data/.